Last reviewed · How we verify
Chemotherapy-Induced Hypogonadism
Approved treatments
- Androgel · Besins Hlthcare
- Testosteron · Gulhane School of Medicine
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chemotherapy-Induced Hypogonadism patent landscape — cliff calendar, originator estates, attackable patents
- Chemotherapy-Induced Hypogonadism treatment landscape brief
- Chemotherapy-Induced Hypogonadism treatment updates RSS
Frequently asked questions about Chemotherapy-Induced Hypogonadism
What drugs treat Chemotherapy-Induced Hypogonadism?
Tracked treatments include Androgel, Testosteron.
What is the treatment for Chemotherapy-Induced Hypogonadism?
Standard treatment for Chemotherapy-Induced Hypogonadism includes Androgel, Testosteron. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chemotherapy-Induced Hypogonadism patent cliff · Chemotherapy-Induced Hypogonadism CI report
- Treatment: Androgel · Besins Hlthcare
- Treatment: Testosteron · Gulhane School of Medicine
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing